Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2026)
Voyager Therapeutics (VYGR) posted Receivables - Other of $151000.0 for Q1 2026, little changed sequentially from $151000.0 in Q4 2025, and down 68.99% YoY from $487000.0 in Q1 2025.
Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2026) Analysis & Trends
Voyager Therapeutics has reported Receivables - Other for 8 years, with the latest figure at $151000.0 in Q1 2026.
- Quarterly Receivables - Other fell 68.99% year-over-year to $151000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151000.0 (down 68.99% YoY) and the FY2025 annual result came in at $151000.0, down 77.66% from the prior year.
- Receivables - Other held at $151000.0 in Q1 2026 per VYGR's latest filing, from $151000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $3.7 million in Q3 2024 and troughed at $151000.0 in Q2 2022.
- A 5-year average of $1.3 million and a median of $676000.0 in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other slumped 91.41% in 2022, then surged 2118.54% in 2023.
- Over 5 years, Receivables - Other stood at $257000.0 in 2022, then soared by 1200.0% to $3.3 million in 2023, then tumbled by 79.77% to $676000.0 in 2024, then tumbled by 77.66% to $151000.0 in 2025, then changed by 0.0% to $151000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $151000.0, $151000.0, and $851000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222,000.00 |
| Jun 30, 2026 | 222,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Sep 30, 2025 | 851,000.00 |
| Sep 30, 2025 | 851,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Sep 30, 2024 | 3.71 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.62 Mn |